New COVID-19 Report
Hello John,

Treatment Advocacy Center is proud to announce the publication of a new research report on COVID-19 vaccination for people with severe mental illness.

People with serious mental illness are often on the outskirts of society, hidden from view of the public and policymakers. As a result, individuals with the most severe psychiatric disorders, including schizophrenia and severe bipolar disorder, are often overlooked or ignored by governmental policy. This invisibility was never more apparent than in response to the COVID-19 pandemic.  

The Treatment Advocacy Center Office of Research and Public Affairs partnered with Clubhouse International, a community-based organization of 326 Clubhouses throughout the world, to conduct an international survey in May of all Clubhouses to understand barriers and facilitators of COVID-19 vaccination among Clubhouse members.
Our survey received responses from 148 Clubhouses, including 116 from Clubhouses in the U.S. and 32 from those outside the U.S.
Estimated vaccination rates of U.S.-based Clubhouse members are, on average, significantly higher than the U.S. population. For example, in one county in Georgia, only 10.1% of the county’s population was fully vaccinated at the time of the survey, compared with an estimated 61–80% of Clubhouse members. 

These dramatic findings suggest that community investment in people with serious mental illness can have a tremendous impact on their health and well-being.

Read the full report here on our website.

"As the COVID-19 pandemic continues to have a devastating impact on the world, the successful efforts of Clubhouses to facilitate vaccination should be seen as an example of the benefits that targeted outreach and support programs can have for people living with serious mental illness, " said Director of Research Elizabeth Sinclair Hancq.

You can read our previous research reports here.

Thank you for your ongoing support of our mission.  

Sincerely, 
Treatment Advocacy Center
Thank you for your continued support of the Treatment Advocacy Center. 
Treatment Advocacy Center | Website